This document summarizes discussions from Days 1 and 2 of an IMCHA mid-term meeting. Key points discussed include:
- The importance of stakeholder engagement, policy relevance of research evidence, learning lessons from past projects, and strengthening implementation research capacity.
- Participants discussed how to design rigorous yet flexible research, strengthen communication of results, and build sustainable capacity at all levels.
- Cross-cutting issues like measuring innovation, scaling up successful approaches, and engaging new partners were also addressed.
- Attendees made commitments to applying research findings, strengthening engagement with policymakers, and documenting lessons learned from their projects.
A presentation by Rachel Hinton as part of the Cohort Research for Programme and Policy panel discussion at the International Symposium on Cohort and Longitudinal Studies in Developing Contexts, UNICEF Office of Research - Innocenti, Florence, Italy 13-15 October 2014
A presentation by Nalini Takeshwar as part of the Cohort Research for Programme and Policy panel discussion at the International Symposium on Cohort and Longitudinal Studies in Developing Contexts, UNICEF Office of Research - Innocenti, Florence, Italy 13-15 October 2014
Theory Based Approach to Planning, Monitoring and Evaluating in the Livestock...ILRI
Presented by Caroline Kanyuuru, Helen Altshul and Helena Posthumus at the Priority Country Planning Meeting (Ethiopia, Tanzania, Uganda, Vietnam), ILRI, Nairobi, 26–27 March 2019
A presentation by Rachel Hinton as part of the Cohort Research for Programme and Policy panel discussion at the International Symposium on Cohort and Longitudinal Studies in Developing Contexts, UNICEF Office of Research - Innocenti, Florence, Italy 13-15 October 2014
A presentation by Nalini Takeshwar as part of the Cohort Research for Programme and Policy panel discussion at the International Symposium on Cohort and Longitudinal Studies in Developing Contexts, UNICEF Office of Research - Innocenti, Florence, Italy 13-15 October 2014
Theory Based Approach to Planning, Monitoring and Evaluating in the Livestock...ILRI
Presented by Caroline Kanyuuru, Helen Altshul and Helena Posthumus at the Priority Country Planning Meeting (Ethiopia, Tanzania, Uganda, Vietnam), ILRI, Nairobi, 26–27 March 2019
A presentation by Respichius Mitti as part of the Practicalities of Cohort and Longitudinal Research panel discussion at the International Symposium on Cohort and Longitudinal Studies in Developing Contexts, UNICEF Office of Research - Innocenti, Florence, Italy 13-15 October 2014
“State of capacities and needs for greater evidence-based policy making in developing Asian countries” presented by Suresh Babu, IFPRI at the ReSAKSS-Asia Conference, Nov 14-16, 2011, in Kathmandu, Nepal.
“Illustration of a proposed ReSAKSS-Asia website tool”, presented by Michael Johnson and Bingxin Yu, IFPRI at the ReSAKSS-Asia Conference, Nov 14-16, 2011, in Kathmandu, Nepal.
Transferring the purchasing role from international to national organizations...valéry ridde
Presentation of Isidore Sieleunou realised for an organised session on Application and challenges to the use of mixed methods in health systems research, held at HSR 2016, the Fourth Global Symposium on Health Systems Research, Vancouver, 14-18 november 2016.
This NAP Global Network event highlighted how to use the Toolkit for a Gender-Responsive Process to Formulate and Implement NAPs to ensure gender equality is considered in the assessment of vulnerabilities and identification of adaptation options.
"The JSR Experience and Scaling Up in East and Central Africa" presented by Joseph Karugia, ReSAKSS East and Central Africa Coordinator, International Livestock Research Institute (ILRI), Kenya, at 2014 ReSAKSS Annual Conference, Addis Ababa, Ethiopia, October 8-10 2014
Nancy Hey - Evidence informed policy making - 26 June 2017OECD Governance
Presentation by Nancy Hey, Director What Works Centre for Wellbeing, United Kingdom, at the event on Governing better through evidence-informed policy making, 26-27 June 2017. The event was organised by the OECD Directorate for Public Governance in cooperation with the European Commission’s Joint Research Centre (JRC), the Campbell Collaboration and the International Network for Government Science Advice (INGSA). For further information please see http://www.oecd.org/gov/evidence-informed-policy-making.htm
Gender-responsive NAP processes: Introduction | Angie Dazé, IISDNAP Global Network
Presentation by Angie Dazé, IISD, as part of the webinar "Gender-Responsive NAP Processes" in March 2018. You can watch a recording of this webinar here: https://www.youtube.com/watch?v=jY9J7zhCdoY
The failure of researchers to link evidence to policy and practice produces evidence that no one uses, impedes innovation, and leads to mediocre or even detrimental development policies. To help improve the definition, design, and implementation of policy research, researchers should adopt a strategic outcome-oriented approach.
A presentation by Respichius Mitti as part of the Practicalities of Cohort and Longitudinal Research panel discussion at the International Symposium on Cohort and Longitudinal Studies in Developing Contexts, UNICEF Office of Research - Innocenti, Florence, Italy 13-15 October 2014
“State of capacities and needs for greater evidence-based policy making in developing Asian countries” presented by Suresh Babu, IFPRI at the ReSAKSS-Asia Conference, Nov 14-16, 2011, in Kathmandu, Nepal.
“Illustration of a proposed ReSAKSS-Asia website tool”, presented by Michael Johnson and Bingxin Yu, IFPRI at the ReSAKSS-Asia Conference, Nov 14-16, 2011, in Kathmandu, Nepal.
Transferring the purchasing role from international to national organizations...valéry ridde
Presentation of Isidore Sieleunou realised for an organised session on Application and challenges to the use of mixed methods in health systems research, held at HSR 2016, the Fourth Global Symposium on Health Systems Research, Vancouver, 14-18 november 2016.
This NAP Global Network event highlighted how to use the Toolkit for a Gender-Responsive Process to Formulate and Implement NAPs to ensure gender equality is considered in the assessment of vulnerabilities and identification of adaptation options.
"The JSR Experience and Scaling Up in East and Central Africa" presented by Joseph Karugia, ReSAKSS East and Central Africa Coordinator, International Livestock Research Institute (ILRI), Kenya, at 2014 ReSAKSS Annual Conference, Addis Ababa, Ethiopia, October 8-10 2014
Nancy Hey - Evidence informed policy making - 26 June 2017OECD Governance
Presentation by Nancy Hey, Director What Works Centre for Wellbeing, United Kingdom, at the event on Governing better through evidence-informed policy making, 26-27 June 2017. The event was organised by the OECD Directorate for Public Governance in cooperation with the European Commission’s Joint Research Centre (JRC), the Campbell Collaboration and the International Network for Government Science Advice (INGSA). For further information please see http://www.oecd.org/gov/evidence-informed-policy-making.htm
Gender-responsive NAP processes: Introduction | Angie Dazé, IISDNAP Global Network
Presentation by Angie Dazé, IISD, as part of the webinar "Gender-Responsive NAP Processes" in March 2018. You can watch a recording of this webinar here: https://www.youtube.com/watch?v=jY9J7zhCdoY
The failure of researchers to link evidence to policy and practice produces evidence that no one uses, impedes innovation, and leads to mediocre or even detrimental development policies. To help improve the definition, design, and implementation of policy research, researchers should adopt a strategic outcome-oriented approach.
A strategic approach to policy engagement for research organisationsJames Georgalakis
This is the presentation delivered as part of a two day workshop held in Nepal in 2014 aimed at communications professionals or the point person for communication within fifteen South Asian think tanks. Participants explored how they could adopt a systematic approach to planning research or knowledge outputs for policy engagement and influence. They explored the types of influencing outcomes they are focused on and their individual and institutional capacities to deliver strategic communication and policy engagement work. By the end of the workshop it was hoped that each participating institution would have identified a clear set of steps towards the development of a strategic approach to policy engagement and research communication at an institutional or programmatic level.
This workshop formed part of the IDRC funded Think Tanks Initiative South Asia programme. http://www.idrc.ca/EN/Programs/Social_and_Economic_Policy/Think_Tank_Initiative/Pages/About.aspx
The following resource was developed by RESYST for a research uptake workshop held in Kilifi, Kenya.
In this resource:
- Understand the importance of strategic planning for research uptake
- Familiarise key aspects of a research uptake strategy
- Develop research uptake objectives for your research group, project, hub or an event
- Identify key stakeholders using stakeholder analysis techniques
- Review communications channels, outputs and activities
- Explore indicators and tools for monitoring and evaluation
- Key questions to consider in a research uptake strategy
Find more: http://resyst.lshtm.ac.uk/resources/resource-bank-research-uptake
Planning and Conducting Advocacy at National and Subnational LevelsCORE Group
Fall Global Health Practitioner Conference 2017
Planning and Conducting Advocacy at National and Subnational Levels
Kavita Sethuraman, Annie Toro, & Danielle Heilberg
Social Marketing for Behaviour Change: Topic: Ethics in Tanzania Jim Mintz
There is a long history internationally of social marketing programs being run in developing countries in social and health areas, however, at the time of CEPSM’s involvement, there were no examples of successfully applying social marketing in the advancement of ethics in government.
This project yielded a diverse set of lessons learned.
• Although the process of social marketing is quite resilient there are major challenges implementing social marketing in a setting with very little modern technology, and unique culture and language differences.
• If you use a disciplined approach to social marketing planning which includes an extensive environmental scan, conducting marketing research and developing effective marketing mix strategies your chance of success is quite good.
• It is important to train your developing country client on how to develop & implement a social marketing strategy and plan so when you leave they have the skills to continue to implement the strategy
• Developing countries do not have access to funds so you need to be innovative and find low cost ways to conduct marketing research and implement social marketing tactics.
• There are many stakeholders involved in social marketing initiatives in the developing world so your social marketing strategy needs to take into consideration the involvement of several outside groups. (e.g. non-state actors)
The Youth Mental Health Network showcased its work to senior NHS and Social Care Leaders at the launch of the South East Strategic Clinical Network on 1st may 2013.
From evidence to actions: How can we use evidence to better inform investment...ILRI
Presented by Isabelle Baltenweck, Peter Ballantyne and Michael Victor at the Global Livestock Advocacy for Development (GLAD) Virtual workshop for sustainable livestock champions, 19–21 May 2020
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
3. What is policy relevant evidence?
We are in this together
• Researchers have to show how the evidence can be used to change the
system and improve lives.
• Researchers need to understand the policy making process and the
national agenda
• Researchers should be able to understand the mind of the policy maker
• Policy makers need capacity to understand evidence that fits into the
national agenda
• Policy maker should demand for more evidence syntheses from IRTs and
HPROs
• HPROs can strengthen capacities around evidence-informed health policy
making
4. What have we learned?
Stakeholder engagement is the foundation – trust is everything
• Stakeholder engagement should be comprehensive, continuous,
cross-sectional, horizontal across peers and vertical across levels.
• Value of embedding research process in context and amongst
stakeholders
• Key stakeholders include:
• government – high-level decision-makers
• Community and local authorities – demand, accountability, sustainability
• Stakeholder engagement at international, national and local levels are
necessary fo rth success of the projects
5. What have we learned?
Keep the ends in mind
• Build the nation
• Address national priorities
• Put the community at the centre
• Support integrated development - adapt technologies to context; transfer technical
skills (Malawi, Mozambique)
• Build the system
• Link research with national health system and policy making processes
• Sustainability is key
• Ensure strong exit plans
• Give special consideration for conflict areas – just leaving can worsen situation
6. What have we learned?
How to do it – rigorous and flexible research design
• Context matters and influences conduct of research
• Take time to do a grounded baseline (South Sudan, Mozambique)
• test initial assumptions to refine and improve overall design
• Apply rigorous equity and gender analytical lenses
• Select appropriate methodologies –
• Not automatically RCTs – focus on implementation research
• Consider new approaches (satellite imagery for sampling)
• Use technologies to strengthen the system; GIS to track health workers; real-time
health information systems
• Importance of qualitative methodologies
7. What have we learned?
How to do it – communication and KT
• Understand and respond to the politics – who presents? Best timing?
• Create accessible interactive platform and clearing house of results,
experiences, lessons
• HPRO-designed platform ready by August/September 2017
• Social media, social media, social media
8. What have we learned?
How to do it – capacity strengthening
• Comprehensive capacity strengthening at all levels
• Community, policy makers, researchers
• Key elements: ability, authority, resources, responsibility
• Particular need for implementation research capacity and how to
continuously apply research results
9. What have we learned?
How to do it – monitoring, learning, evaluation
• Harmonized monitoring and evaluation to show the results
• Learning by doing - document learning process and contribute to
development of ‘good practices’
• Need harmonized tool to document experiences
• Build the field –
• take time to publish articles on implementation research experiences,
processes and challenges
• HPRO support needed
10. What have we learned?
The cross cutting issues
• Innovation – what does it mean? How to measure?
• Scale up – what mechanisms?
• Emerging issues – how to make a difference – ASRH, fragile states
• How to bring new actors on board – political scientists, mental health
experts, other funding and policy partnerships
11. Our commitments
Policy Makers
• Take the results and apply them
• Take to the governor
• Remember the communities
IRTs
• Strengthen engagement with policy makers
• Use the media
• Actively request support from HPROs
• Specific ideas of teams: national meeting of all Tanzania teams, taking Bauchi
experience to federal level, document changes in Bajenu Gox
13. Your plans?
• What is the Innovation your are hunting for?
• What does it mean?
• How to measure?
• Innovation is disruptive
• Who are your interested parties? How to align those?
• How will you manage disruption?
• Sustainability and Scale up – what mechanisms?
• Commitments and Next steps?
Editor's Notes
Policy makers – panel (Tanzania, Malawi, Nigeria, Senegal)
Policy maker survey
Collective reflection – as policy makers; as researchers
IRTs – presentations
Lessons – plenary comments; final synthesis session
Policy makers – panel (Tanzania, Malawi, Nigeria, Senegal)
Policy maker survey
Collective reflection – as policy makers; as researchers
IRTs – presentations
Lessons – plenary comments; final synthesis session
